The Early-Morning Pharmacist
A pharmacy manager notices that a staff pharmacist has been arriving 90 minutes before opening, often alone, and has volunteered for every evening shift. The narcotic cabinet count for liquid morphine is consistently short by small amounts-2 to 5 mL-after those shifts. The pharmacist's handwriting has become shaky, and a technician reports finding the pharmacist asleep in the break room with a syringe cap nearby. The pharmacist is well liked, has 12 years of service, and recently divorced. The manager confronts the pharmacist, who denies diversion and asks the manager not to tell anyone because 'it would ruin my career.' The pharmacy is due for a DEA inspection next month. The manager asks whether to report to the Board, confront the pharmacist with the technician, or wait for the DEA inspection. A patient has already complained that her morphine dose 'didn't work' twice.
1. What is the manager's immediate duty regarding patient safety and the pharmacist's access?
Read the worked answer
The manager's first duty is patient safety. The pharmacist should be removed from patient care and from access to controlled substances immediately, pending investigation. That means not scheduling the pharmacist alone, changing cabinet codes, and ensuring another pharmacist checks all controlled substances. The manager should arrange for the pharmacist to leave the work area in a safe and respectful manner, not publicly humiliate him, and should document objective observations: arrival times, count discrepancies, handwriting changes, the technician's report, and the patient complaints. The manager should not promise confidentiality about diversion or impairment. A promise not to tell anyone would conflict with the manager's legal and ethical duties and could compromise the investigation. The pharmacy must continue to operate with a pharmacist who has not been implicated.
2. Does the situation require reporting to the Board or DEA? Explain the reasoning.
Read the worked answer
Suspected impairment and diversion are reportable concerns. The manager should report to the New Hampshire Board of Pharmacy under its disciplinary and impaired-practitioner provisions, and should not wait for the DEA inspection. If the morphine shortage is confirmed as a theft or significant loss, the DEA must be notified in writing within one business day of discovery, using DEA Form 106. The manager should not decide the case alone; legal counsel and the owner should be involved, but delay for the inspection is not acceptable. The report should stick to objective facts and avoid diagnosing the pharmacist. The pharmacist's 12 years of service and recent divorce may explain stress, but they do not override the reporting duty. If the pharmacist self-reports and enters an approved recovery program, that may affect discipline, but it does not erase the diversion investigation.
3. How should the manager handle the technician, the patient complaint, and due process?
Read the worked answer
The technician should be interviewed privately, asked to write a factual statement, and protected from retaliation. The manager should not stage a confrontation between the technician and the pharmacist, which could intimidate the technician and contaminate the investigation. The patient complaint that morphine 'didn't work' twice should trigger a review of those prescriptions, lot numbers, and administration or use dates, and a determination whether the product may have been tampered with or diluted. If tampering is possible, affected patients and prescribers may need to be notified. Due process for the pharmacist means a fair investigation, an opportunity to respond to the evidence, and access to employee assistance or a recovery program, not a guarantee of continued practice. The manager should document all steps and keep the Board report consistent with the internal findings. Patient safety comes before the pharmacist's career preferences.